Trials / Completed
CompletedNCT04731584
Systemic Inflammation During Recanalization of Cerebral Arterial Occlusion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Strokes management, secondary to proximal arterial occlusion, by endovascular thrombectomy (TM) is now well established. The immuno-inflammatory events of reperfusion after TM are discussed. Systemic inflammation is a major factor suggested to explain the limited recovery of the ischemic parenchyma. Understanding these phenomena is necessary before developing an immunomodulatory strategy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sample | Patients from 2 groups will undergo blood sample (during a blood sample for there care) and inflammation parameters will be measure the day of the stroke |
Timeline
- Start date
- 2021-04-07
- Primary completion
- 2021-06-12
- Completion
- 2021-06-12
- First posted
- 2021-02-01
- Last updated
- 2023-02-13
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04731584. Inclusion in this directory is not an endorsement.